SEC Form 4 · accession 0001104659-17-052248
PRA Health Sciences, Inc. · PRAH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Colin Shannon
Officer — President & CEO · Director
Period of report
Aug 14, 2017
Accepted (ET)
Aug 16, 2017 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613859
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 14, 2017 | S | 400,000 | $74.85 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amount represents the secondary price per share of common stock, par value $0.01 per share, of PRA Health Sciences, Inc. received by the reporting person in an underwritten secondary block trade.